From: Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
S/no
Structure
pIC50
1
5.69
2
5.91
3
5.76
4
5.43
5
5.59
6
5.63
7
5.49